歐舒丹(00973.HK)約503萬歐元收購澳洲護膚品牌Grown Alchemist股權
歐舒丹(00973.HK)公佈,將向公司主席Reinold Geiger擁有控股權益的LOG所擁有大多數股權的LOGI,收購目標公司14 Groupe S.A.的49.24%股權(佔76.18%投票權),而14 Groupe S.A.持有澳洲護膚品牌Grown Alchemist的65%股權及投票權,代價約503萬歐元。
於收購事項後,LOGI將不再爲14 Groupe S.A.的股東,而Grown Alchemist將成爲集團的非全資附屬公司,其財務將於集團綜合入賬。
於收購事項完成後,集團將取代LOGI成爲股東協議訂約方,據此集團將向各餘下股東授出認沽期權,以出售該餘下股東擁有的期權權益予集團;及各餘下股東將向公司授出認購期權,以收購該餘下股東擁有的期權權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.